Treatment of 22 Cases of Medication-Induced Rhinitis by Mometasone Furoate AqueousNasal Spray

VernacularTitle:糠酸莫米松鼻喷雾剂治疗药物性鼻炎22例
Author: Jingying WEN ; Na NING ; Hongtao ZHEN
Publication Type:Journal Article
Keywords: Mometasone furoate aqueous nasal spray; Naphazoline; Rhinitis,drug-induced; Rebound
From: Herald of Medicine 2015;(3):341-343
CountryChina
Language:Chinese
Abstract: Objective To assess the clinical efficiency and side effects of topical mometasone furoate aqueous nasal spray for patients with naphazoline-induced rebound rhinitis. Methods A prospective, non-randomized and self-controlled study was applied. A total of 22 patients with naphazoline-induced rhinitis received two spray-puffs of 50 μg mometason furoate twice daily to each nostril in the morning for one week, followed by two spray-puffs of 50 μg mometason furoate once daily to each nostril every morning for another three weeks after withdrawn of naphazoline therapy. Nasal congestion was evaluated by visual an-alogue scale (VAS) recorded before and after treatment. Side effects like nose bleeding and perforation of the nasal septum was detected with rhinoscope. Results The statistical difference of VAS before and after treatment was significant. No adverse reac-tions as nose bleeding and perforation of the nasal septum were observed by the end of treatment. Conclusion It is safe and effective to use mometasone furoate aqueous nasal spray for treating rebound rhinitis induced by misuse of naphazoline nasal drop.